AEG35156, a novel second-generation antisense oligonucleotide directed towards XIAP, increased sensitization of pancreatic carcinoma cells to TRAIL–mediated apoptosis as a single agent and was capable of inducing complete tumor regression when combined with taxanes in three human cancer xenograft models (prostate, colon, and lung) [157]. Here, TNFSF10 is linked to cancer.